Comparison of docetaxel and docetaxel–irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial
Titel:
Comparison of docetaxel and docetaxel–irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial
Auteur:
Pectasides, D. Pectasides, M. Farmakis, D. Kostopoulou, V. Nikolaou, M. Gaglia, A. Koumpou, M. Mylonakis, N. Xiros, N. Economopoulos, T. Raptis, S.A.